Advertisement
Screener

ANIXA BIOSCIENCES, INC. (ANIX) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

ANIXA BIOSCIENCES, INC. Increase (Decrease) in Accrued Liabilities

ANIXA BIOSCIENCES, INC. (ANIX) reported Increase (Decrease) in Accrued Liabilities of -$344.00 thousand for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-09-09

  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-07-31 was $212.00K, a 14.59% increase year-over-year.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-04-30 was $159.00K, a 21.67% decline year-over-year.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-01-31 was -$715.00K.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-10-31 was $10.00K, a 96.27% decline year-over-year.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$185.00K, a 205.11% decline from fiscal 2024.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $176.00K, a 300.00% increase from fiscal 2023.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $44.00K, a 93.03% decline from fiscal 2022.
  • ANIXA BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $631.00K, a 226.94% increase from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 9 month as first filedIncrease (Decrease) in Accrued Liabilities 12 monthIncrease (Decrease) in Accrued Liabilities 12 month as first filed
2026-07-31$212.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09
$371.00K
derived: sum of 2 quarters · filed 2026-09-09
-$344.00K
10-Q · filed 2026-09-09
-$334.00K
derived: sum of 4 quarters · filed 2026-09-09
2026-04-30$159.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10
-$556.00K
10-Q · filed 2026-06-10
-$546.00K
derived: sum of 3 quarters · filed 2026-06-10
-$361.00K
derived: sum of 4 quarters · filed 2026-09-09
2026-01-31-$715.00K
10-Q · filed 2026-03-09
-$705.00K
derived: sum of 2 quarters · filed 2026-03-09
-$520.00K
derived: sum of 3 quarters · filed 2026-09-09
-$317.00K
derived: sum of 4 quarters · filed 2026-09-09
2025-10-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12
$195.00K
derived: sum of 2 quarters · filed 2026-09-09
$398.00K
derived: sum of 3 quarters · filed 2026-09-09
-$185.00K
10-K · filed 2026-01-12
2025-07-31$185.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09
$388.00K
derived: sum of 2 quarters · filed 2026-09-09
-$195.00K
10-Q · filed 2026-09-09
$73.00K
derived: sum of 4 quarters · filed 2026-09-09
2025-04-30$203.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10
-$380.00K
10-Q · filed 2026-06-10
-$112.00K
derived: sum of 3 quarters · filed 2026-06-10
$156.00K
derived: sum of 4 quarters · filed 2026-06-10
2025-01-31-$583.00K
10-Q · filed 2026-03-09
-$315.00K
derived: sum of 2 quarters · filed 2026-03-09
-$47.00K
derived: sum of 3 quarters · filed 2026-03-09
$121.00K
derived: sum of 4 quarters · filed 2026-03-09
2024-10-31$268.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12
$536.00K
derived: sum of 2 quarters · filed 2026-01-12
$704.00K
derived: sum of 3 quarters · filed 2026-01-12
$176.00K
10-K · filed 2026-01-12
2024-07-31$268.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10
$436.00K
derived: sum of 2 quarters · filed 2025-09-10
-$92.00K
10-Q · filed 2025-09-10
-$34.00K
derived: sum of 4 quarters · filed 2025-09-10
2024-04-30$168.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28
-$360.00K
10-Q · filed 2025-05-28
-$302.00K
derived: sum of 3 quarters · filed 2025-05-28
$117.00K
derived: sum of 4 quarters · filed 2025-05-28
2024-01-31-$528.00K
10-Q · filed 2025-03-11
-$470.00K
derived: sum of 2 quarters · filed 2025-03-11
-$51.00K
derived: sum of 3 quarters · filed 2025-03-11
$167.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-10-31$58.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10
$477.00K
derived: sum of 2 quarters · filed 2025-01-10
$695.00K
derived: sum of 3 quarters · filed 2025-01-10
$44.00K
10-K · filed 2025-01-10
2023-07-31$419.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06
$637.00K
derived: sum of 2 quarters · filed 2024-09-06
-$14.00K
10-Q · filed 2024-09-06
$514.00K
derived: sum of 4 quarters · filed 2024-09-06
2023-04-30$218.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-06-04
-$433.00K
10-Q · filed 2024-06-04
$95.00K
derived: sum of 3 quarters · filed 2024-06-04
$235.00K
derived: sum of 4 quarters · filed 2024-06-04
2023-01-31-$651.00K
10-Q · filed 2024-03-12
-$123.00K
derived: sum of 2 quarters · filed 2024-03-12
$17.00K
derived: sum of 3 quarters · filed 2024-03-12
-$167.00K
derived: sum of 4 quarters · filed 2024-03-12
2022-10-31$528.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16
$668.00K
derived: sum of 2 quarters · filed 2024-01-16
$484.00K
derived: sum of 3 quarters · filed 2024-01-16
$631.00K
10-K · filed 2024-01-16
2022-07-31$140.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-06
-$44.00K
derived: sum of 2 quarters · filed 2023-09-06
$103.00K
10-Q · filed 2023-09-06
$207.00K
derived: sum of 4 quarters · filed 2023-09-06
2022-04-30-$184.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-06-14
-$37.00K
10-Q · filed 2023-06-14
$67.00K
derived: sum of 3 quarters · filed 2023-06-14
$79.00K
derived: sum of 4 quarters · filed 2023-06-14
2022-01-31$147.00K
10-Q · filed 2023-03-17
$251.00K
derived: sum of 2 quarters · filed 2023-03-17
$263.00K
derived: sum of 3 quarters · filed 2023-03-17
$268.00K
derived: sum of 4 quarters · filed 2023-03-17
2021-10-31$104.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04
$116.00K
derived: sum of 2 quarters · filed 2023-01-04
$121.00K
derived: sum of 3 quarters · filed 2023-01-04
$193.00K
10-K · filed 2023-01-04
$193.91K
10-K · filed 2022-01-04
2021-07-31$12.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-09
$17.00K
derived: sum of 2 quarters · filed 2022-09-09
$89.00K
10-Q · filed 2022-09-09
$88.70K
10-Q · filed 2021-09-01
$174.31K
derived: sum of 4 quarters · filed 2022-09-09
2021-04-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-06-10
$77.00K
10-Q · filed 2022-06-10
$77.87K
10-Q · filed 2021-06-10
$162.31K
derived: sum of 3 quarters · filed 2022-06-10
$127.87K
derived: sum of 4 quarters · filed 2022-06-10
2021-01-31$72.00K
10-Q · filed 2022-03-11
$71.81K
10-Q · filed 2021-03-11
$157.31K
derived: sum of 2 quarters · filed 2022-03-11
$122.87K
derived: sum of 3 quarters · filed 2022-03-11
$267.99K
derived: sum of 4 quarters · filed 2022-03-11
2020-10-31$85.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04
$50.87K
derived: sum of 2 quarters · filed 2022-01-04
$195.99K
derived: sum of 3 quarters · filed 2022-01-04
$5.53K
10-K · filed 2022-01-04
2020-07-31-$34.44K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01
$110.68K
derived: sum of 2 quarters · filed 2021-09-01
-$79.78K
10-Q · filed 2021-09-01
-$60.05K
derived: sum of 4 quarters · filed 2021-09-01
2020-04-30$145.12K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-10
-$45.34K
10-Q · filed 2021-06-10
-$25.62K
derived: sum of 3 quarters · filed 2021-06-10
-$27.69K
derived: sum of 4 quarters · filed 2021-06-10
2020-01-31-$190.46K
10-Q · filed 2021-03-11
-$170.74K
derived: sum of 2 quarters · filed 2021-03-11
-$172.81K
derived: sum of 3 quarters · filed 2021-03-11
-$9.11K
derived: sum of 4 quarters · filed 2021-03-11
2019-10-31$19.73K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07
$17.66K
derived: sum of 2 quarters · filed 2021-01-07
$181.36K
derived: sum of 3 quarters · filed 2021-01-07
$212.40K
10-K · filed 2021-01-07
2019-07-31-$2.07K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-08
$161.63K
derived: sum of 2 quarters · filed 2020-09-08
$192.67K
10-Q · filed 2020-09-08
$165.71K
derived: sum of 4 quarters · filed 2020-09-08
2019-04-30$163.70K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-09
$194.74K
10-Q · filed 2020-06-09
$167.78K
derived: sum of 3 quarters · filed 2020-06-09
-$10.31K
derived: sum of 4 quarters · filed 2020-06-09
2019-01-31$31.04K
10-Q · filed 2020-03-09
$4.08K
derived: sum of 2 quarters · filed 2020-03-09
-$174.01K
derived: sum of 3 quarters · filed 2020-03-09
$44.51K
derived: sum of 4 quarters · filed 2020-03-09
2018-10-31-$26.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09
-$205.05K
derived: sum of 2 quarters · filed 2020-01-09
$13.47K
derived: sum of 3 quarters · filed 2020-01-09
$273.93K
10-K · filed 2020-01-09
2018-07-31-$178.09K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06
$40.42K
derived: sum of 2 quarters · filed 2019-09-06
$300.89K
10-Q · filed 2019-09-06
$269.45K
derived: sum of 4 quarters · filed 2019-09-06
2018-04-30$218.52K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12
$478.98K
10-Q · filed 2019-06-12
$447.55K
derived: sum of 3 quarters · filed 2019-06-12
$676.48K
derived: sum of 4 quarters · filed 2019-06-12
2018-01-31$260.46K
10-Q · filed 2019-03-13
$229.03K
derived: sum of 2 quarters · filed 2019-03-13
$457.96K
derived: sum of 3 quarters · filed 2019-03-13
$486.36K
derived: sum of 4 quarters · filed 2019-03-13
2017-10-31-$31.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11
$197.50K
derived: sum of 2 quarters · filed 2019-01-11
$225.90K
derived: sum of 3 quarters · filed 2019-01-11
$313.64K
10-K · filed 2019-01-11
2017-07-31$228.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07
$257.34K
derived: sum of 2 quarters · filed 2018-09-07
$345.07K
10-Q · filed 2018-09-07
2017-04-30$28.40K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-06-11
$116.14K
10-Q · filed 2018-06-11
2017-01-31$87.74K
10-Q · filed 2018-03-09
2016-10-31$89.47K
10-K · filed 2018-01-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ProMIS Neurosciences Inc. (PMN)$0.102B
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92